Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Interview: Salvador Cardona, CEO, Milenia Labs

Milenia Labs links Mexican diagnostic centres with lab groups in the United States, Canada and Spain to provide specialized tests. We speak to CEO Salvador Cardona about expanding in Latin America and potentially moving into provision.

FREE BLOG Theranos may have failed, but it radically changed the lab sector

Theranos posited the idea that you could do a bunch of very low cost tests from pharmacies. Whilst it has so far failed to deliver on this, that threat has changed the sector. There are now plenty more newbies who want to do the same, such as Brainshake, whose CEO we interview here.

Interview: Teemu Suna, CEO, Finnish biomedical company Brainshake

Brainshake is a Finnish biomedical company that claims to revolutionise blood testing. It tests for over 200 biomarkers opening a far broader window into the health state of an individual than existing blood tests. And despite beginning commercial operations just three years ago, it already has global ambitions and claims to be highly profitable – enough to secure €5m of primarily non-equity funding. We interviewed its CEO Teemu Suna.

FREE BLOG Two business models we didn’t think would fly

A few years ago we scratched our heads and dismissed two very different business ideas as “no-goers” – teleradiology and formalising “Ladies from the East.” How wrong we were. For many years teleradiology really didn’t look like a flyer. Public sector hospitals  didn’t want to outsource image interpretation to the private sector. And (very well […]

The future of healthcare in Nigeria: PPPs and the NHIS?

Healthcare investors generally take a fancy to Nigeria. Africa’s most populous country has a growing middle class and will one day finally put some distance between itself and South Africa as its largest economy. The petrodollars already flow freely into healthcare. But no one has bothered to keep them in the country: not the existing fragmented private sector, nor the government, which has other priorities – President Buhari has been treated in London, after all! So, surely, all that’s left to do is fly in, start a JV with a local partner, consolidate and cut off the medical tourism leak at source?

Medlife buys Bucharest operator

Romania’s largest private healthcare provider Medlife has just completed yet another acquisition. The group bought a 90% stake in Panduri Medical Centre, which runs two labs and two clinics in Bucharest. We speak to one consultant about its strategy.

India’s SRL and Fortis to “uncouple”

Fortis Healthcare and SRL Diagnostics, India’s second largest hospital group and largest lab group respectively, are demerging so private equity investors can exit and it can offer specialised hospital and lab stock picks. SRL’s CEO Sanjeev Vashista told Healthcare Nova SRL has eight years left on its contracts with Fortis, which will, in any case, remain a majority shareholder.

Nordics’ independent labs diversify

Over the past decade, independent labs in the Nordics have had to endure dropping prices and the arrival of giant diagnostic players keen to consolidate. They are now trying to change their strategies.

What impact will clarity on quality outcomes have on healthcare services?

We are about to find out the answer to that question. From April 2017, the UK’s Private Healthcare Information Network (PHIN) will go live with a mammoth website representing nearly 2 million datapoints covering the output of 14,000 consultant doctors with private practice at over 500 hospitals. Over 200 procedures will be measured in 11 ways. What does all this mean?

Find Us